M&A Deal Summary

Allergan Acquires Exemplar Pharma

On April 12, 2013, Allergan acquired medical products company Exemplar Pharma for 20M USD

Acquisition Highlights
  • This is Allergan’s 5th transaction in the Medical Products sector.
  • This is Allergan’s 8th largest (disclosed) transaction.
  • This is Allergan’s 11th transaction in the United States.
  • This is Allergan’s 3rd transaction in Massachusetts.

M&A Deal Summary
Date 2013-04-12
Target Exemplar Pharma
Sector Medical Products
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 20M USD
Advisor(s) Salem Partners (Financial)

Target

Exemplar Pharma

Fall River, Massachusetts, United States
website
Exemplar Pharma LLC manufacture of nasal and inhalation products targeting lungs, nasal passages, and the buccal cavity.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Irvine, California, United States
Category Company
Founded 1948
Sector Life Science
Employees11,400
DESCRIPTION

Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.

DEAL STATS #
Overall 11 of 14
Sector (Medical Products) 5 of 6
Type (Add-on Acquisition) 10 of 13
State (Massachusetts) 3 of 3
Country (United States) 11 of 14
Year (2013) 2 of 2
Size (of disclosed) 8 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-22 MAP Pharmaceuticals

Mountain View, California, United States

MAP Pharmaceuticals, Inc. is a specialty pharmaceutical company developing innovative therapies and inhalation delivery platforms to treat a broad spectrum of respiratory and systemic diseases.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-29 Lap-Band System

United States

The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume.

Sell $110M
Mergr

Product

Company

Legal